Advertisement

American Heart Association Scientific Sessions

newsroom

News
Research Summaries
Insights
Podcasts Q&As

Featured

AHA Scientific Sessions
Erin Michos
AHA Scientific Sessions
Erin Michos, MD, on Reducing CVD Outcomes With Influenza Vaccination
02/05/2022
02/05/2022
ARRHYTHMIA
podcasts360 logo
ARRHYTHMIA
The Influence of Atrial Fibrillation on Cardiac Amyloidosis
01/11/2022
In this podcast, Temitope Ajibawo, MD, MPH, answers our questions about his team's study on how atrial fibrillation affects mortality and thromboembolic complications in patients who are hospitalized with...
01/11/2022
bleeding
Yoshihiro Tanaka
bleeding
Yoshihiro Tanaka, MD, PhD, on Predicting Bleeding Risk in Patients With AFib Taking DOACs
12/26/2021
In this podcast, Yoshihiro Tanaka, MD, PhD, answers our questions about his team's study on predicting bleeding risk among patients with atrial fibrillation who are taking direct oral anticoagulants instead...
12/26/2021
Advertisement

Conference Coverage

TREATMENT
medication
TREATMENT
Diabetes Medication Improves Acute Heart Failure Hospitalization Outcomes
11/18/2021
In a recent study presented at the AHA’s Scientific Sessions, researchers examined the primary outcomes of number of deaths, adverse events, time to the first heart failure event, or a KCCQ score that had...
11/18/2021
Anticoagulants and Antiplatelet Agents
Anticoagulants and Antiplatelet Agents
What Is the Optimal Duration of DAPT After Stent Implantation?
11/20/2020
Since the optimal duration of dual antiplatelet therapy remains uncertain, researchers of a recent study examined a 1-month course of DAPT compared with 6 to 12-months of therapy following...
11/20/2020
Treatment
Treatment
Rivaroxaban Is Effective in Patients With Bioprosthetic Mitral Valve
11/20/2020
This direct-acting oral anticoagulant may be superior to the current standard of care anticoagulant for patients with a bioprosthetic mitral valve. In a study presented at AHA Scientific Sessions 2020,...
11/20/2020
Treatment
Treatment
CVD Risk Is Lowered by Polypill, Aspirin
11/19/2020
A reduction in cardiovascular events may be possible with the use of a new combination pill of blood-pressure- and cholesterol-lowering medications. In this trial, the researchers examined how this...
11/19/2020
Hospital Medicine
Hospital Medicine
Heart Failure Status at Presentation for ACS Predicts 1-Year Outcomes
11/11/2018
The researchers assessed the association between heart failure status at presentation for ACS and future ischemic events, rehospitalization for heart failure, and death 1 year after discharge from the...
11/11/2018

Clinical Insights

AHA Scientific Sessions
Erin Michos
AHA Scientific Sessions
Erin Michos, MD, on Reducing CVD Outcomes With Influenza Vaccination
02/05/2022
02/05/2022
ARRHYTHMIA
podcasts360 logo
ARRHYTHMIA
The Influence of Atrial Fibrillation on Cardiac Amyloidosis
01/11/2022
In this podcast, Temitope Ajibawo, MD, MPH, answers our questions about his team's study on how atrial fibrillation affects mortality and thromboembolic complications in patients who are hospitalized with...
01/11/2022
bleeding
Yoshihiro Tanaka
bleeding
Yoshihiro Tanaka, MD, PhD, on Predicting Bleeding Risk in Patients With AFib Taking DOACs
12/26/2021
In this podcast, Yoshihiro Tanaka, MD, PhD, answers our questions about his team's study on predicting bleeding risk among patients with atrial fibrillation who are taking direct oral anticoagulants instead...
12/26/2021
Stroke
Xiaoxi Yao, PhD, MPH
Stroke
Xiaoxi Yao, PhD, MPH, on Guideline-Recommended Anticoagulation Rates
11/24/2021
11/24/2021
Hypertension
Hypertension
Wilbert S. Aronow, MD, on the New Hypertension Guidelines
11/20/2017
The new guidelines issued by the American Heart Association and the American College of Cardiology have essentially changed the definition of hypertension. What does this mean for your practice? Dr. Wilbert...
11/20/2017